Boston Scientific (BSX) has been the "gang who couldn’t shot straight" of the medical device business for some time. It spent far too much money to buy another medical company, Guidant. For…
These are ten of the impact analyst calls we are seeing this Friday morning: Abbott Labs (NYSE: ABT) started as Buy at UBS. Advanced Energy (NASDAQ: AEIS) Raised To Overweight By JP…
Thursday after the close, we’ll get to see earnings out of Genentech (NASDAQ: DNA). The estimates from First Call are $0.82 EPS on $3.11 billion in revenues. Next quarter estimates are $0.86…
These are the top analyst calls we are focusing on early this Thursday morning in pre-market trading: Abbott Laboratories (NYSE: ABT) Raised To Outperform at Wachovia. Altria (NYSE: MO) started as Buy…
Medtronic, Inc. (NYSE: MDT) has just announced that it has received formal approval from the FDA to market its Endeavor Zotarolimus-Eluting Coronary Stent System for the treatment of coronary artery disease. This…
We are full fledged into earnings season now, so most news coverage will point to the current earnings environment and guidance. There are of course drug developments and other contracts awards. Below…
James Tobin, the CEO of Boston Scientific (NYSE:BSX) is likely to find himself in front of the shareholder firing squad in 2008. In early 2004 this stock was above $40 and had…
Abbott Labs (ABT) which just launched a new stent product, Xience V, has laid off 1,200 people because of slowness in the stent market. Stranger than fiction. According to MarketWatch, Abbott says…
According to Reuters, Fed chief Bernanke said the resurgence in financial strains in recent weeks had dimmed the outlook for the U.S. economy. Reuters writes that Dell’s (DELL) profit rose but if…
Abbot Labs (ABT) is trying to get into the stent business. The market has been dominated by Boston Scientific (BSX) and Johnson & Johnson (JNJ). Stents are small mess implants which are…
Boston Scientific (BSX) has been the leader in sales of stents, those little mess tubes that keep arteries open. Recent studies show that the devices are more dangerous than most doctors had…
(ABT) Abbott Labs $0.69 EPS vs $0.68 estimate; guidance looks soft.(ASD) American Standard $0.84 EPS net, but $1.05 before items; estimates were $1.08. Spin-off/sale remains on track. (BLK) Blackrock $1.80 EPS vs…
MONDAYMattel (NYSE:MAT)Novellus (NASDAQ:NVLS)Philips Electronics (NYSE:PHG/ADR)W.W. Grainger (NYSE:GWW) TUESDAYJohnson & Johnson (NYSE:JNJ)Intel Corporation (NASDAQ: INTC)Merrill Lynch (NYSE:MER)Novartis (NYSE:NVS/ADR)Pharmaceutical Product Development (NASDAQ:PPDI)SLM Corp. (NYSE:SLR)State Street (NYSE:STT)Coca Cola (NYSE:KO)Wells fargo (NYSE:WFC)Yahoo! (NASDAQ:YHOO) WEDNESDAYAbbott Labs (NYSE:ABT)Altria…
GE’s (GE) share price has had a bit of a run over the last three months. Until that point, the stock was flat with where it traded in July 2005. Now, two…
According to Reuters, Rio Tinto (RTP) has launched a $38.1 billion takeover bid for Alcan (AL). Reuters writes that customers at JP Morgan have been confused by opposite calls on future plans…
